Peripheral blood mononuclear cells (PBMC) and DNA.
Working to improve the quality of life of patients undergoing hematopoietic transplantation through the research and development of new therapeutic strategies, as well as promoting the dissemination of scientific knowledge related to these types of transplants, cell therapy and cooperation between teams specialized in this disease.